Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5142)
All Articles published online
|
Nov 7, 2011 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Patel K, Friedrich-Rust M, Lurie Y, Grigorescu M, Stanciu C, Lee CM, Schiff ER, Häussinger D, Manns MP, Gerken G, Colle I, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG, Zeuzem S. FibroSURE™ and FibroScan® in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol 2011; 17(41): 4581-4589 [PMID: 22147963 DOI: 10.3748/wjg.v17.i41.4581] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i41/4581.htm |
| Number | Citing Articles |
| 1 |
Giada Sebastiani, Konstantinos Gkouvatsos, Kostas Pantopoulos. Chronic hepatitis C and liver fibrosis. World Journal of Gastroenterology 2014; 20(32): 11033-11053 doi: 10.3748/wjg.v20.i32.11033
|
| 2 |
Mirella Fraquelli, Ilaria Fanetti, Andrea Costantino. Elastography of the Liver and Beyond. 2021; : 119 doi: 10.1007/978-3-030-74132-7_9
|
| 3 |
Thierry Poynard, Jordi Bruix, Eugene R. Schiff, Moises Diago, Thomas Berg, Ricardo Moreno-Otero, Andre C. Lyra, Flair Carrilho, Louis H. Griffel, Navdeep Boparai, Ruiyun Jiang, Margaret Burroughs, Clifford A. Brass, Janice K. Albrecht. Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study. Journal of Hepatology 2013; 58(3): 452 doi: 10.1016/j.jhep.2012.11.001
|
| 4 |
Humberto C. Gonzalez, Andrés Duarte-Rojo. Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes. Current Gastroenterology Reports 2016; 18(7) doi: 10.1007/s11894-016-0508-y
|
| 5 |
Irvin M. Modlin, Mark Kidd, Anna Malczewska, Ignat Drozdov, Lisa Bodei, Somer Matar, Kyung-Min Chung. The NETest. Endocrinology and Metabolism Clinics of North America 2018; 47(3): 485 doi: 10.1016/j.ecl.2018.05.002
|
| 6 |
Thierry Poynard, Joseph Moussalli, Mona Munteanu, Dominique Thabut, Pascal Lebray, Marika Rudler, Yen Ngo, Vincent Thibault, Helmi Mkada, Frederic Charlotte, Françoise Imbert Bismut, Olivier Deckmyn, Yves Benhamou, Marc Antoine Valantin, Vlad Ratziu, Christine Katlama. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C. Journal of Hepatology 2013; 59(4): 675 doi: 10.1016/j.jhep.2013.05.015
|
| 7 |
Ivan Gentile, Nicola Coppola, Giuseppe Pasquale, Raffaele Liuzzi, Maria D’Armiento, Maria Emma Di Lorenzo, Nicolina Capoluongo, Antonio Riccardo Buonomo, Evangelista Sagnelli, Filomena Morisco, Nicola Caporaso, Guglielmo Borgia. A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C. Hepatitis Monthly 2013; 13(5) doi: 10.5812/hepatmon.8352
|
| 8 |
Thomas Reiberger, Sabela Lens, Giuseppe Cabibbo, Pierre Nahon, Anna Linda Zignego, Katja Deterding, Ahmed M. Elsharkawy, Xavier Forns. EASL position paper on clinical follow-up after HCV cure. Journal of Hepatology 2024; 81(2): 326 doi: 10.1016/j.jhep.2024.04.007
|
| 9 |
Marianne Pavel, Henning Jann, Vikas Prasad, Ignat Drozdov, Irvin M. Modlin, Mark Kidd. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive. Neuroendocrinology 2017; 104(2): 170 doi: 10.1159/000446025
|
| 10 |
Andres Duarte-Rojo, Bachir Taouli, Daniel H. Leung, Deborah Levine, Tarek Nayfeh, Bashar Hasan, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Samir Haffar, Ayca Dundar, M. Hassan Murad, Don C. Rockey, Mouaz Alsawas, Richard K. Sterling. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology 2024; doi: 10.1097/HEP.0000000000000852
|
| 11 |
K. E. Sherman. Therapeutic Approach to the Treatment-Naive Patient With Hepatitis C Virus Genotype 1 Infection: A Step-by-Step Approach. Clinical Infectious Diseases 2012; 55(9): 1236 doi: 10.1093/cid/cis628
|
| 12 |
Anna Malczewska, Mark Kidd, Kjell Öberg, Lisa Bodei, Alexander Mandel, Alexandra Kitz, Irvin M. Modlin. Neuroendocrine Tumours. 2024; : 81 doi: 10.1007/978-3-031-56968-5_6
|
| 13 |
Sherif El Saadany, Hanan Soliman, Dina H. Ziada, Manal Hamisa, Mohamed Hefeda, Amel Selim, Hussien Goraba. Fibroscan versus liver biopsy in the evaluation of response among the Egyptian HCV infected patients to treatment. The Egyptian Journal of Radiology and Nuclear Medicine 2016; 47(1): 1 doi: 10.1016/j.ejrnm.2015.12.007
|
| 14 |
Anna Malczewska, Beata Kos-Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Oberg, Irvin M. Modlin. The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors. Advances in Medical Sciences 2020; 65(1): 18 doi: 10.1016/j.advms.2019.10.002
|
| 15 |
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
|
| 16 |
Antonia Lepida, Massimo Colombo, Inmaculada Fernandez, Djamal Abdurakhmanov, Paulo Abrao Ferreira, Simone I. Strasser, Petr Urbanek, Alessandra Mangia, José L. Calleja, Wafae Iraqi, Ralph DeMasi, Isabelle Lonjon-Domanec, Christophe Moreno, Heiner Wedemeyer, Vincent Wong. Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis. PLOS ONE 2015; 10(9): e0138503 doi: 10.1371/journal.pone.0138503
|
| 17 |
Siddharth Singh, Andrew J. Muir, Douglas T. Dieterich, Yngve T. Falck-Ytter. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology 2017; 152(6): 1544 doi: 10.1053/j.gastro.2017.03.016
|
| 18 |
Keyur Patel, Giada Sebastiani. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Reports 2020; 2(2): 100067 doi: 10.1016/j.jhepr.2020.100067
|
| 19 |
Richard K. Sterling, Keyur Patel, Andres Duarte-Rojo, Sumeet K. Asrani, Mouaz Alsawas, Jonathan A. Dranoff, Maria Isabel Fiel, M. Hassan Murad, Daniel H. Leung, Deborah Levine, Tamar H. Taddei, Bachir Taouli, Don C. Rockey. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 2024; doi: 10.1097/HEP.0000000000000845
|
| 20 |
Delphine Bonnet, Matthieu Guivarch, Emilie Bérard, Jean-Marc Combis, Andre Jean Remy, Andre Glibert, Jean-Louis Payen, Sophie Metivier, Karl Barange, Herve Desmorat, Anaïs Palacin, Florence Nicot, Florence Abravanel, Laurent Alric. Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients. World Journal of Hepatology 2014; 6(9): 660-669 doi: 10.4254/wjh.v6.i9.660
|